Role of Lysine-Specific Demethylase 1 in Angiotensin II-Induced Hypertensive Kidney Disease

Background: Hypertension is a major contributor to chronic kidney disease (CKD) and end-stage kidney disease. Angiotensin II (Ang II), a key effector of the renin-angiotensin system, promotes tubular injury, inflammation, and fibrosis. Epigenetic regulators such as lysine-specific demethylase 1 (LSD1) have emerged as important modulators of gene expression and cellular stress responses. However, the role of LSD1 in hypertensive kidney disease remains unclear. Methods: To investigate the function of LSD1 in hypertensive CKD, we utilized a tamoxifen-inducible LSD1 knockout mouse model. Mice were subjected to vehicle or Ang II infusion via osmotic minipumps. Kidney tissues were analyzed for histopathological changes, fibrotic, and molecular signaling pathways involved in cell cycle regulation and fibroblast activation. Cultured tubular epithelial cells and fibroblasts were used to investigate the role of LSD1 in regulating tubular epithelial cell dedifferentiation and fibroblast activation in vitro. Results: Ang II infusion induced LSD1 expression in tubular epithelial cells and myofibroblasts. LSD1-deficient mice exhibited protection against Ang II-induced kidney disease with reduced tubular damage. Further, LSD1-deficient mice displayed significant less inflammatory infiltration and fibrosis. Expression of fibrosis markers such as α-SMA, fibronectin, and collagen I was significantly reduced. Inflammatory cytokines including MCP-1 and IL-6 were considerably downregulated in LSD1-deficient mice following Ang II infusion. Additionally, LSD1 deficiency inhibited G2/M cell cycle arrest and suppressed activation of Smad3, a key profibrotic signaling. Conclusion: LSD1 plays a pathogenic role in Ang II-induced hypertensive kidney disease by promoting epithelial cell injury, inflammation, and fibrotic remodeling. Targeting LSD1 may provide a novel epigenetic-based therapeutic approach to limit CKD progression in patients with hypertension. Funding: NIDDK Support

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025t7sy1kaf
Primary Topic
Folate and B Vitamins Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Role of Lysine-Specific Demethylase 1 in Angiotensin II-Induced Hypertensive Kidney Disease

Baihai Jiao, Dong Yang, Melanie Tran, Yanlin Wang et al.
Journal of the American Society of Nephrology
Folate and B Vitamins Research
article

Role of Lysine-Specific Demethylase 1 in Angiotensin II-Induced Hypertensive Kidney Disease

Baihai Jiao, Dong Yang, Melanie Tran, Yanlin Wang, Hao Du
article en

Abstract

Background: Hypertension is a major contributor to chronic kidney disease (CKD) and end-stage kidney disease. Angiotensin II (Ang II), a key effector of the renin-angiotensin system, promotes tubular injury, inflammation, and fibrosis. Epigenetic regulators such as lysine-specific demethylase 1 (LSD1) have emerged as important modulators of gene expression and cellular stress responses. However, the role of LSD1 in hypertensive kidney disease remains unclear. Methods: To investigate the function of LSD1 in hypertensive CKD, we utilized a tamoxifen-inducible LSD1 knockout mouse model. Mice were subjected to vehicle or Ang II infusion via osmotic minipumps. Kidney tissues were analyzed for histopathological changes, fibrotic, and molecular signaling pathways involved in cell cycle regulation and fibroblast activation. Cultured tubular epithelial cells and fibroblasts were used to investigate the role of LSD1 in regulating tubular epithelial cell dedifferentiation and fibroblast activation in vitro. Results: Ang II infusion induced LSD1 expression in tubular epithelial cells and myofibroblasts. LSD1-deficient mice exhibited protection against Ang II-induced kidney disease with reduced tubular damage. Further, LSD1-deficient mice displayed significant less inflammatory infiltration and fibrosis. Expression of fibrosis markers such as α-SMA, fibronectin, and collagen I was significantly reduced. Inflammatory cytokines including MCP-1 and IL-6 were considerably downregulated in LSD1-deficient mice following Ang II infusion. Additionally, LSD1 deficiency inhibited G2/M cell cycle arrest and suppressed activation of Smad3, a key profibrotic signaling. Conclusion: LSD1 plays a pathogenic role in Ang II-induced hypertensive kidney disease by promoting epithelial cell injury, inflammation, and fibrotic remodeling. Targeting LSD1 may provide a novel epigenetic-based therapeutic approach to limit CKD progression in patients with hypertension. Funding: NIDDK Support

Journal of the American Society of NephrologyVol. 36(10S)
University of Connecticut (US)
Openalex Percentile: Top 56%
Folate and B Vitamins Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.